Home/Filings/4/A/0001567619-20-021618
4/A//SEC Filing

SHULMAN JOHN D 4/A

Accession 0001567619-20-021618

CIK 0001815903other

Filed

Dec 27, 7:00 PM ET

Accepted

Dec 28, 7:46 PM ET

Size

36.7 KB

Accession

0001567619-20-021618

Insider Transaction Report

Form 4/AAmended
Period: 2020-12-01
Transactions
  • Award

    Common Stock, par value $0.0001 per share

    2020-12-01+3,395,9643,395,964 total(indirect: See Footnote)
Transactions
  • Award

    Common Stock, par value $0.0001 per share

    2020-12-01+3,395,9643,395,964 total(indirect: See Footnote)
Transactions
  • Award

    Common Stock, par value $0.0001 per share

    2020-12-01+3,395,9643,395,964 total(indirect: See Footnote)
Transactions
  • Award

    Common Stock, par value $0.0001 per share

    2020-12-01+3,395,9643,395,964 total(indirect: See Footnote)
SHULMAN JOHN D
Director10% Owner
Transactions
  • Award

    Common Stock, par value $0.0001 per share

    2020-12-01+3,395,9643,395,964 total(indirect: See Footnote)
Transactions
  • Award

    Common Stock, par value $0.0001 per share

    2020-12-01+3,395,9643,395,964 total(indirect: See Footnote)
Footnotes (3)
  • [F1]This amended Form 4 is being filed to add Reporting Persons and to adjust the number of securities acquired to account for the same.
  • [F2]See Note (1) in Exhibit 99.1.
  • [F3]See Note (2) in Exhibit 99.1.

Issuer

Petros Pharmaceuticals, Inc.

CIK 0001815903

Entity typeother

Related Parties

1
  • filerCIK 0001208886

Filing Metadata

Form type
4/A
Filed
Dec 27, 7:00 PM ET
Accepted
Dec 28, 7:46 PM ET
Size
36.7 KB